Related articles
-
CareersMy autistic academic maze - and my advice to neurodiverse PhD students
In Neurodiversity Celebration Week, PhD student Joshua Yates reveals the challenges of pursuing a career in microbiology with autism and dyslexia - and his advice to others.
-
News2025 Gut Microbiota for Health World Summit to spotlight groundbreaking research
The 13th Gut Microbiota for Health World Summit, taking place March 15-16 in Washington, D.C., will reveal how cutting-edge research on gut microbiome science is being applied to clinical practice.
-
NewsSymptoms of long-COVID can last up to two years after infection with COVID-19
According to a study of the COVICAT cohort, almost one in four people infected with SARS-CoV-2 suffered from long-COVID. In more than half of them the symptoms persisted for two years.
More from News
-
NewsRestoring vegetation cover in Amazon's pasture areas can reduce methane emissions, study reveals
Proper pasture management in the Amazon, aimed at maintaining soil vegetation cover, can reduce methane emissions from livestock farming, according to a new study analyzing emissions and microorganisms in Amazonian soil.
-
NewsTecovirimat is safe but ineffective as treatment for clade II mpox
The antiviral drug tecovrimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control among adults in an international clinical trial.
-
NewsDrug may prevent COVID-19 in exposed people within households, major trial finds
An international clinical trial of the oral antiviral drug, ensitrelvir, which has been proved to prevent COVID-19 cases, was conducted and found to be very effective. The drug will be awaiting for approval before becoming widely available.
No comments yet